Human Papillomavirus : Common Sexually Transmitted Infection Essay

HPV is so common in the United States that nearly all men and women will contract the virus at some point during life (Center for Disease Control and Prevention [CDC], 2017). In the United States, in 2008, it is reported that 3.2 million, or one in four adolescent women, ages 14 to 19 have had or have an STD (Kostas-Polston et al., 2012). The rate of HPV cases has only increased since 2008. The prevalence of a genital infection with any HPV type was 42.5% among United States during 2013–2014 (CDC, 2017). The incidence of HPV in the United States is about 14 million people each year.

Human Papilloma Virus (HPV) is the most commonly sexually transmitted disease in the United States. It is estimated that at least 80% of men and women acquire an HPV infection during their lifetime. “In a recent study of women in the United States 25% of fourteen to nineteen year olds were infected with at least one type of HPV. HPV is often acquired within a few months of sexual initiation, even among people with only one partner”. (Contemporary OB/GYN) Men are the main carriers of this infection but once a woman has been exposed to the infection she is also a carrier of HPV. Once a person has been

Genital human papillomavirus (HPV) is the most common sexually transmitted virus in the United States. Most sexually active people will have genital HPV at some time in their lives. Most people who have genital HPV don’t know they have it. There are often no symptoms, and it goes away on its own, without causing any serious health problems. HPV is passed on through genital contact, and you can pass HPV to others without knowing it. There is no cure for HPV, but there

Human Papillomavirus is a sexually transmitted disease that infects over twenty million Americans each year (Vanslyke, Baum, Plaza, Otero, Wheeler, Helizter, 2008, P. 584). Many of these people do not realize that they are infected because they do not show any symptoms. Even though HPV has been talked about for decades, it is only until recent years that the topic has become part of mainstream women’s health issues. Not only that, many of these people are women who do not understand the importance of testing for HPV. HPV is one of the leading causes of cervical cancer among women.

Among the many arguments for mandatory HPV vaccination, the foremost is that it is an important medical achievement and a major public health milestone. This vaccine has proven to be one-hundred percent effective in preventing the 4 HPV strains that are responsible for seventy percent of cervical cancers and ninety percent of genital warts. In addition, no serious side effects have been identified. Because this vaccine is a preventive measure, administration before onset of sexual activity is ideal; however, even females who have been sexually active can still benefit from this vaccination (Perkins et al., 2010). Nationally and internationally, the HPV vaccine will significantly reduce disease burden by reducing monetary and psychological costs of invasive procedures that remove precancerous and cancerous lesions. By combining vaccination with routine Pap smear screening, these public health efforts have the remarkable opportunity to eradicate cervical cancer (Ramet et al., 2011).

Human papillomavirus is an infection that comes in many different varieties. There are over a 100 varieties of the infection. It was first identified in 1956 by a team of scientists. The virus can range in severity between sub-clinical, up to cancerous. The infection itself is not a cancer but may lead to cancer. Many individuals may not even know that they have HPV.

The numbers are mind-boggling, but they are continuously rising each year. However, as mentioned early on advocates affirm that pharmaceutical companies have become proactive upon the issue and introduced an HPV vaccine to the public. In 2006, an HPV vaccine/cervical cancer vaccine known as Gardasil was put on the market. Gardasil has been proven to be safe and effective in preventing not only genital warts, but certain strains of HPV that cause cervical cancer as well.

This vaccine was considered a break through due to the fact it was the first vaccine developed to fight against cancer. The HPV vaccine, commonly called Gardasil, only endured six months of testing before being approved. Typically, vaccines go through several years of evaluation before it is made available to the public. The research found that the vaccine is nearly 100% effective at its job; however, it only works when given prior to exposure to the illness (Ballaro). For this reason, it is recommended that people should receive the vaccine at age eleven or twelve. Originally, the vaccine was only available for women between the ages of eleven and twenty-six (Ballaro). This was most likely due to the fact that women are more susceptible to develop cancers from an HPV infection. In 2014, the vaccine was approved to be given to men between the ages of eleven and twenty-one (Frey). Men up to age twenty-six can receive the vaccine if their immune system is compromised or if they have had sex with another man as gay and bisexual men are 17 times more likely to develop a cancer from HPV than straight men. (Frey; McGill). The vaccine is given in three shots and all are essential to receive total protection. Another type of vaccine, Cervarix, was created in 2009 to prevent HPV types 16 and 18. Cervarix does not protect from genital wart like Gardasil does and it is only available for women (Frey). Both vaccines can save

Human Papillomavirus is a sexually transmitted infection that it is acquired through vaginal, anal or oral sex with someone who is infected. Just like most STI’s HPV does not discriminate. It can affect men and women, the young and the old. The best way to protect you from contracting the infection is to abstain from sexual activity, have a monogamous relationship or wear condoms at all times.

The population targeted for the HPV vaccine is males and females 9-26 years of age, preferably before the initiation of sexual activity (Valentino & Poronsky, 2016). The number of male and female adolescents protected by the HPV vaccine falls drastically short of the current “Healthy People 2020 target of 80%” (Valentino & Poronsky, 2016). Failure to educate these adolescents and their caregivers puts them at risk of not receiving the potentially lifesaving vaccine.

Research proves that certain cervical cancers can be prevented by simply getting vaccinated against the Human Papillomavirus (Shafer, Cates, Diehl, & Hartmann, 2011). This virus is responsible for 99% of the cervical cancers (Smith, 2008). The Human Papillomavirus (HPV) is the most sexually transmitted disease in the world (Nath &Thappa, 2009). Four main strains of HPV exists, 6,11,16 and 18 (Smith, 2008). HPV strains 16 and 18 are the causative factors for 70% of the cervical cancers (Smith, 2008). HPV strains 6 and 11 cause about 90% of genital warts (Smith, 2008). Without serious side effects the Human Papillomavirus (HPV) Vaccine is 100% effective in preventing the two HPV strains that cause the largest percentages of cervical cancer

The HPV vaccine protects people from the type of HPV that causes cervical cancer and genital warts. The vaccines allows the body’s immune system to produce antibodies to certain HPV types. They come in a series of three shots and you must get these three shots within six months. ( IN-TEXT CITATION: https://www.plannedparenthood.org/learn/stds-hiv-safer-sex/hpv/hpv-vaccine) Males and Females ages 9 to 26 should get the HVP vaccine.

The Human Papillomavirus also known as HPV is the most common sexualy transmitted infection. Currently there are millions of people in USA with HPV. It’s so common, nearly sexually active people get HPV at some point in their lives. Doctor’s now use a vaccine to prevent HPV. Alot of people don’t know they have been infected because it may take years to have any signs or symptoms.

Human Papillomavirus (HPV) is a sexually transmitted disease (STD). “Approximately 20 million Americans are infected with HPV as of 2009, and another 6.2 million people become newly infected each year” (Langwith, 2013, p.16). There are many causes for HPV including vaginal sex, oral sex, anal sex, abrasions of skin, and passing of HPV between mother and child during a vaginal birth. The effects of HPV after being contracted include cancer, genital warts, planter warts, and palmer warts.

But, there is a way to prevent human papillomavirus infection. It is by vaccination. There are two vaccines that have been approved for use in the United States to prevent cervical cancer. Cervarix, a bivalent vaccine-protecting against HPV-16 and HPV-18, and has been approved to vaccinate females from the ages of 9-25. Gardasil, a quadrivalent vaccine-protecting against HPV-6, HPV-11, HPV-16, and HPV-18, and is approved for vaccination of females from the ages of 9-26 to prevent genital warts, cervical cancer, to prevent precancerous lesions, and vaccination of males from ages 9-26 to prevent genital warts (Ermel,